Hand-Foot-and-Mouth Disease in Emergency Medicine

Back

Practice Essentials

Hand-foot-and-mouth (HFM) disease is a viral syndrome with a distinct exanthem-enanthem.

This clearly recognizable syndrome is characterized by vesicular lesions on the mouth and an exanthem on the hands and feet (and buttocks) in association with fever. See the images below.



View Image

The lower lip has an ulcer with an erythematous halo.



View Image

The tongue has an ulcer with an erythematous halo.



View Image

A typical cutaneous lesion has an elliptical vesicle surrounded by an erythematous halo. The long axis of the lesion is oriented along the skin lines.....

Pathophysiology

Hand-foot-and-mouth disease is caused by a group of RNA viruses called enteroviruses. The most commonly implicated enterovirus is coxsackievirus A16.[1] However, coxsackieviruses A5, A9, A10, A16, B1, and B3; human enterovirus 71 (HEV71); as well as herpes simplex viruses (HSV) can cause the illness.

Cases are commonly spread via the fecal-oral or oral-oral route. Respiratory droplet transmission also may occur but is less likely. Typically, the virus seeds the GI tract via the buccal mucosa or the ileum. Over the next 72 hours (accounting for the incubation period), a viremia is established via spread through nearby lymph nodes.[2]

Epidemiology

Frequency

International

Distribution of this disease is worldwide, with a peak incidence in the summer and fall in temperate climates and with no seasonal pattern in the tropics.

The largest population-based study of the epidemiology of hand, foot, and mouth disease was conducted in China to better inform vaccine and other interventions. Between 2008 and 2012, the Chinese Center for Disease Control and Prevention recorded 7,200,092 probable cases of hand, foot, and mouth disease (annual incidence, 1·2 per 1000 person-years from 2010-12). Mortality (rare in developed countries) and incidence were highest in children aged 12-23 months.[3]

Mortality/Morbidity

This illness has, essentially, a full recovery rate. However, HEV71 has been recently implicated in several large outbreaks in the Far East with severe complications and deaths. Complications are rare, but as with any pruritic rash, a secondary skin infection may occur.

Severe complications may occur when CNS or cardiopulmonary involvement is present. These sequelae include dysphagia, limb weakness, cardiopulmonary failure, and even death. Although death is very rare, it is most often due to pulmonary hemorrhage or edema.

Enteroviruses as a group are a cause of aseptic meningitis and encephalitis; however, Hand-foot-and-mouth disease is not usually associated with meningitis.[4]

A study that included 1280 stool specimens from pediatric patients hospitalized for treatment of HFMD in China reported that EV71 and CA16 were the most common agents for severe and critical HFM.[18]

Sex

Males and females are affected with equal frequency. Males are more likely to become symptomatically ill.

Age

Hand-foot-and-mouth disease, as well as severe disease complications, are more common among infants and children younger than 5 years.

History

The usual incubation period of hand-foot-and-mouth (HFM) disease is 4-6 days.

The prodrome is associated with the following:

The prodrome precedes the development of oral lesions, followed shortly by skin lesions, primarily on the hands and feet and occasionally on the buttocks.

Physical

Hand-foot-and-mouth disease is the most common cause of mouth sores in pediatric patients.

Yellow ulcers surrounded by red halos characterize the oral lesions. These primarily occur on the labial and buccal mucosal surfaces but may be observed on the tongue, palate, uvula, anterior tonsillar pillars, or gums. Unlike herpetic gingivostomatitis, perioral lesions are uncommon. Coxsackie A virus also causes herpangina, mostly described as palatal and posterior oropharyngeal lesions without any associated exanthem. The oral ulcers are painful. Children younger than 5 years are predominately more symptomatic than older patients.[5]

The exanthem typically involves the dorsal surfaces but frequently may include the palmar, plantar, and interdigital surfaces of the hands and feet. These lesions may be asymptomatic or pruritic. They usually begin as erythematous macules that rapidly progress to thick-walled grey vesicles with an erythematous base. In young infants, these lesions may also be observed on the trunk, thighs, and buttocks. The rash is usually self-limited, lasting approximately 3-6 days. Case reports have documented subacute, chronic, and recurring skin lesions.

Causes

See the list below:

Laboratory Studies

See the list below:

Emergency Department Care

See the list below:

Medication Summary

No specific therapy for hand-foot-and-mouth (HFM) disease has been identified. Antibiotics are not indicated unless a complicating secondary skin infection is present.

Standard dosages of antipyretics (eg, acetaminophen, ibuprofen) are recommended on an as-needed basis for fever and analgesia.

Codeine can be used for significant pain that is not controlled with ibuprofen or acetaminophen. Topical treatments include diphenhydramine and lidocaine (or benzocaine). Lidocaine or benzocaine should only be applied with a cotton swab (and infrequently) to specific areas to avoid toxicity.[8]

Acetaminophen (Feverall, Tempra, Tylenol)

Clinical Context:  Inhibits action of endogenous pyrogens on heat-regulating centers; reduces fever by a direct action on the hypothalamic heat-regulating centers, which, in turn, increase the dissipation of body heat via sweating and vasodilation. Effective for treating fever and relieving mild-to-moderate pain.

Ibuprofen (Advil, Motrin)

Clinical Context:  Effective for treating fever or mild-to-moderate pain. Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.

Codeine

Clinical Context:  Indicated for moderate to severe pain. Binds to opiate receptors in CNS, causing inhibition of ascending pain pathways, altering perception and response to pain.

Diphenhydramine (Benylin)

Clinical Context:  Elicits antipruritic activity and weak local anesthetic action. Used topically for temporary relief of pruritus or pain.

Lidocaine anesthetic (Xylocaine)

Clinical Context:  Available as a gel or viscous oral solution. Decreases permeability of neuronal membranes to sodium ions, resulting in inhibition of depolarization and blocking transmission of nerve impulses. Initial treatment of choice for small sparse ulcers. Does not decrease healing time but may allow patient to better tolerate eating and drinking. Pain relief may be short lived, and frequent applications may be necessary.

Benzocaine (Cepacol, Orajel)

Clinical Context:  PABA derivative ester-type local anesthetic, minimally absorbed. Inhibits neuronal membrane depolarization, blocking nerve impulses. Used to control pain.

Class Summary

Pain control is essential for quality patient care. Some analgesics (eg, acetaminophen, ibuprofen) also are effective for treating fever.

Inpatient & Outpatient Medications

Numerous potential remedies for the pain associated with the oral lesions (which may cause the child to decrease oral intake) in hand-foot-and-mouth (HFM) disease have been reported. These remedies have not been studied in any comparative or validated methodology; however, anecdotally they have been successful. These include the following:

Complications

See the list below:

Prognosis

See the list below:

Patient Education

See the list below:

What is hand-foot-mouth (HFM) disease?What is the pathophysiology of hand-foot-mouth (HFM) disease?What is the prevalence of hand-foot-mouth (HFM) disease?What is the mortality associated with hand-foot-mouth (HFM) disease?What are the sexual predilections of hand-foot-mouth (HFM) disease?Which age groups have the highest prevalence of hand-foot-mouth (HFM) disease?What are the signs and symptoms of hand-foot-mouth (HFM) disease?Which physical findings are characteristic of hand-foot-mouth (HFM) disease?What causes hand-foot-mouth (HFM) disease?Which conditions are included in the differential diagnoses of hand-foot-mouth (HFM) disease?What are the differential diagnoses for Hand-Foot-and-Mouth Disease in Emergency Medicine?What is the role of lab tests in the workup of hand-foot-mouth (HFM) disease?How is hand-foot-mouth (HFM) disease treated?What is the role of medications in the treatment of hand-foot-mouth (HFM) disease?Which medications in the drug class Analgesic agents are used in the treatment of Hand-Foot-and-Mouth Disease in Emergency Medicine?How is oral pain managed in hand-foot-mouth (HFM) disease?What are the possible complications of hand-foot-mouth (HFM) disease?What is the prognosis of hand-foot-mouth (HFM) disease?What is included in patient education about hand-foot-mouth (HFM) disease?

Author

Pamela L Dyne, MD, Professor of Clinical Medicine/Emergency Medicine, University of California, Los Angeles, David Geffen School of Medicine; Attending Physician, Department of Emergency Medicine, Olive View-UCLA Medical Center

Disclosure: Nothing to disclose.

Coauthor(s)

Heather Kesler DeVore, MD, Assistant Professor, Clinical Attending Physician, Department of Emergency Medicine, Georgetown University Hospital and Washington Hospital Center

Disclosure: Nothing to disclose.

Stacy Sawtelle, MD, Clinical Instructor, Department of Emergency Medicine, University of California, San Francisco, School of Medicine

Disclosure: Nothing to disclose.

Specialty Editors

Mary L Windle, PharmD, Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Wayne Wolfram, MD, MPH, Professor, Department of Emergency Medicine, Mercy St Vincent Medical Center; Chairman, Pediatric Institutional Review Board, Mercy St Vincent Medical Center, Toledo, Ohio

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD, Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Disclosure: Nothing to disclose.

Additional Contributors

William G Gossman, MD, FAAEM, Associate Clinical Professor of Emergency Medicine, Creighton University School of Medicine; Chairman, Department of Emergency Medicine, Creighton University Medical Center

Disclosure: Nothing to disclose.

References

  1. Suzuki Y, Taya K, Nakashima K, et al. Study on Risk Factors for Severe Hand-foot-and-mouth Disease. Pediatr Int. 2009 Aug 3. [View Abstract]
  2. Wolff K, Johnson RA, Suurmond D. Viral infections of skin and mucosa. Fitzpatrick's Color Atlas & Synopsis of Clinical Dermatology. 5th ed. New York, NY: McGraw-Hill; 2005. 790-92.
  3. Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014 Apr. 14(4):308-18. [View Abstract]
  4. Wang SM, Lei HY, Liu CC. Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis. Clin Dev Immunol. 2012. 2012:876241. [View Abstract]
  5. Lott JP, Liu K, Landry ML, Nix WA, Oberste MS, Bolognia J, et al. Atypical hand-foot-and-mouth disease associated with coxsackievirus A6 infection. J Am Acad Dermatol. 2013 Nov. 69(5):736-41. [View Abstract]
  6. Nassef C, Ziemer C, Morrell DS. Hand-foot-and-mouth disease: a new look at a classic viral rash. Curr Opin Pediatr. 2015 Aug. 27 (4):486-91. [View Abstract]
  7. Kuehnel NA, Thach S, Thomas DG. Onychomadesis as a Late Complication of Hand-Foot-Mouth Disease: A Case Series Shedding Light on Nail Shedding. Pediatr Emerg Care. 2017 Nov. 33 (11):e122-e123. [View Abstract]
  8. Hopper SM, McCarthy M, Tancharoen C, Lee KJ, Davidson A, Babl FE. Topical Lidocaine to Improve Oral Intake in Children With Painful Infectious Mouth Ulcers: A Blinded, Randomized, Placebo-Controlled Trial. Ann Emerg Med. 2013 Nov 7. [View Abstract]
  9. Chang LY, Tsao KC, Hsia SH, et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA. 2004 Jan 14. 291(2):222-7. [View Abstract]
  10. Chen KT, Chang HL, Wang ST, Cheng YT, Yang JY. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. Pediatrics. 2007 Aug. 120(2):e244-52. [View Abstract]
  11. Cherry JD. Enteroviruses: polioviruses, coxsackieviruses, echoviruses and enteroviruses. Textbook of Pediatric Infectious Diseases. 5th ed. 2005. 2007.
  12. Cherry JD. Viral exanthems. Curr Probl Pediatr. 1983 Apr. 13(6):1-44. [View Abstract]
  13. Davis H, Karasic R. Pediatric infectious disease. Atlas of Pediatric Physical Diagnosis. 3rd ed. 1997. 347-8.
  14. Marks M. Viral and presumably viral syndromes. Pediatric Infectious Diseases for the Practitioner. 1985. 494-6.
  15. Sasidharan CK, Sugathan P, Agarwal R, et al. Hand-foot-and-mouth disease in Calicut. Indian J Pediatr. 2005 Jan. 72(1):17-21. [View Abstract]
  16. Wang CY, Li Lu F, Wu MH, et al. Fatal coxsackievirus A16 infection. Pediatr Infect Dis J. 2004 Mar. 23(3):275-6. [View Abstract]
  17. Jones E, Pillay TD, Liu F, Luo L, Bazo-Alvarez JC, Yuan C, et al. Outcomes following severe hand foot and mouth disease: A systematic review and meta-analysis. Eur J Paediatr Neurol. 2018 Sep. 22 (5):763-773. [View Abstract]
  18. Zhao Y, Zhang H, Liu H, Zhang J, He L, Sun H, et al. Molecular characteristics of hand, foot, and mouth disease for hospitalized pediatric patients in Yunnan, China. Medicine (Baltimore). 2018 Aug. 97 (31):e11610. [View Abstract]

The lower lip has an ulcer with an erythematous halo.

The tongue has an ulcer with an erythematous halo.

A typical cutaneous lesion has an elliptical vesicle surrounded by an erythematous halo. The long axis of the lesion is oriented along the skin lines.

The lower lip has an ulcer with an erythematous halo.

The tongue has an ulcer with an erythematous halo.

A typical cutaneous lesion has an elliptical vesicle surrounded by an erythematous halo. The long axis of the lesion is oriented along the skin lines.